Your browser doesn't support javascript.
loading
In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2.
Mulgaonkar, Nirmitee; Wang, Haoqi; Mallawarachchi, Samavath; Ruzek, Daniel; Martina, Byron; Fernando, Sandun.
Afiliação
  • Mulgaonkar N; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX, USA.
  • Wang H; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX, USA.
  • Mallawarachchi S; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX, USA.
  • Ruzek D; Veterinary Research Institute, Brno, and Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Ceske Budejovice, Czech Republic.
  • Martina B; Artemis One Health Research Institute, Delft, The Netherlands.
  • Fernando S; Biological and Agricultural Engineering Department, Texas A&M University, College Station, TX, USA.
J Biomol Struct Dyn ; 41(7): 3052-3061, 2023 04.
Article em En | MEDLINE | ID: mdl-35220926
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: J Biomol Struct Dyn Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos